Cogent Biosciences Competitors and Similar CompaniesClear all
Cogent Biosciences's competitors and similar companies include Orchard Therapeutics, Stealth BioTherapeutics, Ambys Medicines and Lisata Therapeutics.
 Cogent Biosciences Cogent Biosciences (formerly known as Unum Therapeutics) is a biotechnology company that designs precision therapies to treat genetically driven diseases. |  Orchard Therapeutics Orchard Therapeutics is a biotechnology company that develops transformative ex vivo autologous hematopoietic stem cell gene therapy. |  Stealth BioTherapeutics Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction. |  Ambys Medicines Ambys Medicines is a developer of regenerative medicine therapies for serious liver diseases. |  Lisata Therapeutics Lisata Therapeutics is a biopharmaceutical company providing platform technologies for solid tumors and other major diseases treatment. | |
Founding Date | Founding Date 2014 | Founding Date 2015 | Founding Date 2007 | Founding Date 2018 | Founding Date 2006 |
Type | Type Public | Type Subsidiary | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Waltham, US HQ Boulder, US | Locations London, GB HQ Boston, US Boston, US Foster City, US Menlo Park, US | Locations Newton, US HQ Needham, US | Locations Redwood City, US HQ South San Francisco, US | Locations Bernards, US HQ Sydney, AU Dublin, IE Osaka, JP Edinburgh, GB |
Employees | Employees 25826% increase | Employees 166 | Employees 592% decrease | Employees 14 | Employees 257% decrease |
Valuation ($) | Valuation ($) 1.3 b | Valuation ($) N/A | Valuation ($) 18.4 m | Valuation ($) N/A | Valuation ($) 24 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $22.7m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $170k (FY, 2024) |
Net income | Net income ($328.9m) (FY, 2025) | Net income ($150.7m) (FY, 2022) | Net income ($52.5m) (FY, 2021) | Net income N/A | Net income ($16.6m) (FY, 2024) |
Funding | |||||
Total funding raised | Total funding raised $ 178.3m | Total funding raised $ 310.7m | Total funding raised $ 100m | Total funding raised $ 140m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Orchard Therapeutics
HQ
London, GB
Orchard Therapeutics is a biotechnology company that develops transformative ex vivo autologous hematopoietic stem cell gene therapy.
View companyStealth BioTherapeutics
HQ
Newton, US
Employees
59↓ 2% decrease
Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction.
View companyAmbys Medicines
HQ
Redwood City, US
Employees
14
Ambys Medicines is a developer of regenerative medicine therapies for serious liver diseases.
View companyLisata Therapeutics
HQ
Bernards, US
Employees
25↓ 7% decrease
Lisata Therapeutics is a biopharmaceutical company providing platform technologies for solid tumors and other major diseases treatment.
View company